SUMMARY
Adolescents can develop Ankylosing Spondylitis (AS), a form of arthritis linked to the Human Leukocyte Antigen B27 (HLA-B27) gene, which alters immune responses. Environmental factors and bacterial infections may also contribute to the onset of AS. Treatment options include ENBREL, a medication targeting tumor necrosis factor, which helps manage symptoms. Regular physical activity, such as swimming, is crucial for maintaining flexibility and range of motion in affected individuals.
PREREQUISITES
- Understanding of Ankylosing Spondylitis (AS) and its symptoms
- Knowledge of the Human Leukocyte Antigen B27 (HLA-B27) gene
- Familiarity with tumor necrosis factor (TNF) inhibitors like ENBREL
- Awareness of the importance of physical therapy in managing chronic pain
NEXT STEPS
- Research the genetic factors associated with Ankylosing Spondylitis
- Learn about the mechanisms of action of TNF inhibitors like ENBREL
- Explore physical therapy techniques for improving flexibility in AS patients
- Investigate the role of environmental factors in the development of autoimmune diseases
USEFUL FOR
Individuals affected by Ankylosing Spondylitis, healthcare professionals, and anyone seeking to understand the implications of arthritis in adolescents.